While microarray technology is broadening its applications in genomics and proteomics, the technique remains a vibrant contributor in the area of gene expression. Much of the overall developmental ...
CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced that research demonstrating the ...
The ASCO/College of American Pathologists guidelines for the interpretation of the companion diagnostic for trastuzumab have recently been amended to try to address the problem of tumor heterogeneity.
A single microarray can provide information on the expression of tens of thousands of genes. The amount of information generated by a microarray-based experiment is sufficiently large that no single ...
The mutation status of the epidermal growth factor receptor (EGFR) as a selection criterion for therapy with EGFR tyrosine kinase inhibitors (TKI’s) in non-small cell lung cancer (NSCLC) No ...
Vaxxas holds an exclusive license from The University of Texas at Austin (UTA) to the SARS-CoV-2 spike subunit vaccine (HexaPro) for vaccination using a patch. HexaPro, a second-generation SARS-CoV-2 ...
KRAS mutation in the primary or acquired resistance of Chinese NSCLC to EGFR tyrosine kinase inhibitors No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the ...
Thanks to new advances, breast cancer can be a beatable disease, but there is still a lot we do not know about breast cancer. New technology is helping doctors learn more. Researchers at UNC are using ...
Two of the critical issues that arise when examining DNA microarray data are (1) determination of which genes best discriminate among the different types of tissue, and (2) characterization of ...
To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback